Term: nivolumab
IPA: nɪˈvɒljʊˌmæb

==English==
{{wp}}

===Etymology===
From {{af|en|-l-|-umab|t1=immunomodulating|t2=human monoclonal antibody}}.

{{rfe|en}}

===Pronunciation===
* {{IPA|en|/nɪˈvɒljʊˌmæb/}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} a human [[IgG4]] anti-[[PD-1]] [[monoclonal antibody]], acting as a [[checkpoint inhibitor]], thus allowing activated [[T cells]] to attack cancer cells

===Anagrams===
* {{anagrams|en|a=abilmnouv|ovalbumin}}